These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25117462)

  • 1. Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs.
    Araujo S; Bañón S; Machuca I; Moreno A; Pérez-Elías MJ; Casado JL
    Eur J Endocrinol; 2014 Nov; 171(5):545-54. PubMed ID: 25117462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study.
    Lo YC; Chen MY; Sheng WH; Hsieh SM; Sun HY; Liu WC; Wu PY; Wu CH; Hung CC; Chang SC
    HIV Med; 2009 May; 10(5):302-9. PubMed ID: 19220492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.
    Brown TT; Cole SR; Li X; Kingsley LA; Palella FJ; Riddler SA; Visscher BR; Margolick JB; Dobs AS
    Arch Intern Med; 2005 May; 165(10):1179-84. PubMed ID: 15911733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Diabetes Mellitus in Human Immunodeficency Virus positive Patients in Puerto Rico--San Juan City Hospital Experience.
    Hernández-Vázquez LR; Martinez JH; Rivera-Anaya C; Laboy J; Miranda S; Mancilla P; Vélez S
    Bol Asoc Med P R; 2015; 107(3):5-8. PubMed ID: 26742188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
    Capeau J; Bouteloup V; Katlama C; Bastard JP; Guiyedi V; Salmon-Ceron D; Protopopescu C; Leport C; Raffi F; Chêne G;
    AIDS; 2012 Jan; 26(3):303-14. PubMed ID: 22089377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection.
    Visnegarwala F; Chen L; Raghavan S; Tedaldi E
    J Infect; 2005 May; 50(4):331-7. PubMed ID: 15845431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy.
    Palacios R; Merchante N; Macias J; González M; Castillo J; Ruiz J; Márquez M; Gómez-Mateos J; Pineda JA; Santos J
    Antivir Ther; 2006; 11(4):529-35. PubMed ID: 16856627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance.
    Freitas P; Carvalho D; Santos AC; Mesquita J; Matos MJ; Madureira AJ; Martinez E; Sarmento A; Medina JL
    BMC Infect Dis; 2012 Aug; 12():180. PubMed ID: 22866963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus in HIV-infected patients receiving antiretroviral therapy.
    Moyo D; Tanthuma G; Mushisha O; Kwadiba G; Chikuse F; Cary MS; Steenhoff AP; Reid MJ
    S Afr Med J; 2013 Oct; 104(1):37-9. PubMed ID: 24388085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Prevalence of Diabetes Mellitus in a Non-Obese Adult Population: HIV-Infected Ethiopians.
    Tzur F; Chowers M; Agmon-Levin N; Mekori YA; Hershko AY
    Isr Med Assoc J; 2015 Oct; 17(10):620-3. PubMed ID: 26665316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand.
    Lee B; Aurpibul L; Sirisanthana V; Mangklabruks A; Sirisanthana T; Puthanakit T
    HIV Med; 2009 Feb; 10(2):72-8. PubMed ID: 19018877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.
    Tien PC; Schneider MF; Cole SR; Levine AM; Cohen M; DeHovitz J; Young M; Justman JE
    AIDS; 2007 Aug; 21(13):1739-45. PubMed ID: 17690572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy.
    Dejkhamron P; Unachak K; Aurpibul L; Sirisanthana V
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):403-12. PubMed ID: 24259240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance in treated HIV infection.
    Feeney ER; Mallon PW
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):443-58. PubMed ID: 21663838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of insulin resistance in a cohort of HIV-infected youth.
    Rosso R; Parodi A; d'Annunzio G; Ginocchio F; Nicolini L; Torrisi C; Sormani MP; Lorini R; Viscoli C; Vignolo M
    Eur J Endocrinol; 2007 Nov; 157(5):655-9. PubMed ID: 17984246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
    Loko MA; Bani-Sadr F; Winnock M; Lacombe K; Carrieri P; Neau D; Morlat P; Serfaty L; Dabis F; Salmon D;
    J Viral Hepat; 2011 Jul; 18(7):e307-14. PubMed ID: 21692942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overweight HIV patients with abdominal fat distribution treated with protease inhibitors are at high risk for abnormalities in glucose metabolism - a reason for glycemic control.
    Blass SC; Ellinger S; Vogel M; Ingiliz P; Spengler U; Stehle P; von Ruecker A; Rockstroh JK
    Eur J Med Res; 2008 May; 13(5):209-14. PubMed ID: 18559303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of insulin resistance among patients attending the HIV clinic in a Nigerian tertiary hospital.
    Dada AO; Oshodi TT; Ajie IO; Onyenekwu CP
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S607-S610. PubMed ID: 28462827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.